Table 4.
GAD-7 ≥ 10 | PHQ-8 ≥ 10 | GAD-7 or PHQ-8 ≥ 10 | GAD-7 & PHQ-8 ≥ 10 | |
---|---|---|---|---|
Total Sample – % | 12.7 | 14.1 | 17.7 | 9.2 |
Gender – % | ||||
Female (n = 1000) | 14.2 | 15.8 | 19.4 | 10.6 |
Male (n = 570) | 10.2 | 11.2 | 14.7 | 6.7 |
Age Groupb – % | ||||
20–40 years (n = 848) | 17.3 | 17.5 | 22.6 | 12.1 |
41–50 years (n = 398) | 8.3 | 11.8 | 13.8 | 6.3 |
51–82 years (n = 324) | 6.2 | 8.3 | 9.6 | 4.9 |
Income Groupb – % | ||||
$0–$29,999 (n = 372) | 19.1 | 22.3 | 27.2 | 14.2 |
$30,000–$59,999 (n = 418) | 15.3 | 14.6 | 19.9 | 10.0 |
$60,000+ (n = 645) | 8.1 | 9.6 | 11.6 | 6.0 |
The GAD-7 measures symptoms of generalized anxiety and the PHQ-8 measures symptoms of depression; % = percent of subsample (e.g., % of females with scores at or above 10)
aAs determined by Kroenke et al. (2001) and Spitzer et al. (2006)
bAge is presented in three groups, as participants ages 20–30 and 31–40 did not significantly differ in mean GAD-7 or PHQ-8 scores, nor did participants ages 51–60 and 61–82 (see Table 1). Similarly, we collapsed across income groups $60–89,999 and $90,000+, as these groups did not significantly differ in mean GAD-7 or PHQ-8 scores (see Table 1)